1417 related articles for article (PubMed ID: 27282665)
1. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
2. Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: An analysis of bile acids metabolic mechanism.
Song YN; Zhang GB; Lu YY; Chen QL; Yang L; Wang ZT; Liu P; Su SB
J Ethnopharmacol; 2016 Aug; 189():148-56. PubMed ID: 27196295
[TBL] [Abstract][Full Text] [Related]
3. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
4. Flavonoid-rich Scabiosa comosa inflorescence extract attenuates CCl
Ma Y; Yuan H; Jin R; Bao X; Wang H; Su X; Mu MGSL; Liang J; Zhang J; Wu X
Biomed Pharmacother; 2018 Oct; 106():426-433. PubMed ID: 29990830
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation.
Yongping M; Zhang X; Xuewei L; Fan W; Chen J; Zhang H; Chen G; Liu C; Liu P
J Ethnopharmacol; 2015 Jul; 169():200-9. PubMed ID: 25917841
[TBL] [Abstract][Full Text] [Related]
6. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.
Liang B; Guo XL; Jin J; Ma YC; Feng ZQ
World J Gastroenterol; 2015 May; 21(17):5271-80. PubMed ID: 25954100
[TBL] [Abstract][Full Text] [Related]
8. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
Tao YY; Wang QL; Shen L; Fu WW; Liu CH
Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
[TBL] [Abstract][Full Text] [Related]
9. Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor‑β/Smad pathway in rats.
Huang W; Li L; Tian X; Yan J; Yang X; Wang X; Liao G; Qiu G
Mol Med Rep; 2015 Feb; 11(2):805-14. PubMed ID: 25373883
[TBL] [Abstract][Full Text] [Related]
10. LPS-induced macrophage exosomes promote the activation of hepatic stellate cells and the intervention study of total astragalus saponins combined with glycyrrhizic acid.
Deng K; Dai Z; Yang P; Yang D; Zhou Y
Anat Rec (Hoboken); 2023 Dec; 306(12):3097-3105. PubMed ID: 35730909
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
Zhao XM; Zhang J; Liang YN; Niu YC
Dig Dis Sci; 2020 Oct; 65(10):2925-2936. PubMed ID: 31900718
[TBL] [Abstract][Full Text] [Related]
12. [Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/Smads signaling pathway].
Wang QL; Tao YY; Shen L; Cui HY; Liu CH
Zhong Xi Yi Jie He Xue Bao; 2012 May; 10(5):561-8. PubMed ID: 22587979
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
14. [Uniform designed research on the active ingredients assembling of huangqi decoction for inhibition of DMN-induced liver fibrosis].
Tong X; Chen GF; Lu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1389-93. PubMed ID: 22097211
[TBL] [Abstract][Full Text] [Related]
15. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect.
Xu L; Zheng N; He Q; Li R; Zhang K; Liang T
Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.
Xu P; Zhang Y; Liu Y; Yuan Q; Song L; Liu M; Liu Z; Yang Y; Li J; Li D; Ren G
Toxicol Appl Pharmacol; 2016 Jan; 290():43-53. PubMed ID: 26592322
[TBL] [Abstract][Full Text] [Related]
17. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
18. Baihe Wuyao decoction ameliorates CCl
Chen Y; Li R; Hu N; Yu C; Song H; Li Y; Dai Y; Guo Z; Li M; Zheng Y; Guo Z; Qi Y
J Ethnopharmacol; 2020 Dec; 263():113227. PubMed ID: 32783983
[TBL] [Abstract][Full Text] [Related]
19. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.
Pathil A; Mueller J; Ludwig JM; Wang J; Warth A; Chamulitrat W; Stremmel W
Br J Pharmacol; 2014 Nov; 171(22):5113-26. PubMed ID: 25041068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]